NASDAQ:ADVM - Nasdaq - US00773U2078 - Common Stock - Currency: USD
ADVM gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 551 industry peers in the Biotechnology industry. The financial health of ADVM is average, but there are quite some concerns on its profitability. ADVM is quite expensive at the moment. It does show a decent growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -71.49% | ||
ROE | -181.81% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Altman-Z | -9.81 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 5.73 | ||
Quick Ratio | 5.73 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NASDAQ:ADVM (8/8/2025, 8:18:07 PM)
2.29
-0.16 (-6.53%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 47.84 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 0.68 | ||
P/tB | 0.68 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -71.49% | ||
ROE | -181.81% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | N/A | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 10.62% | ||
Cap/Sales | 38.8% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 5.73 | ||
Quick Ratio | 5.73 | ||
Altman-Z | -9.81 |